Belgian provider of genomic testing products for prostate cancer.
Industry: Health Care
Latest Trade: $2.00 0.00 (0.0%)
First Day Return: 0.0%
Return from IPO: -98.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/13/2021 |
Offer Price | $12.00 |
Price Range $12.00 - $12.00 | |
Offer Shares (mm) | 3.8 |
Deal Size ($mm) | $45 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/03/2021 |
Offer Price | $12.00 |
Price Range $12.00 - $12.00 | |
Offer Shares (mm) | 3.8 |
Deal Size ($mm) | $45 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Piper Sandler |
Oppenheimer & Co. |
more |
Company Data | |
---|---|
Headquarters | Herstal, Belgium |
Founded | 2003 |
Employees at IPO | 190 |
Website www.mdxhealth.com |